Craft

Vetoquinol

Stock Price

€80.2

2024-10-29

Market Capitalization

€949 M

2024-10-29

Revenue

€525.7 M

FY, 2025

Vetoquinol Summary

Company Summary

Overview
Vetoquinol is a veterinary pharmaceutical laboratory. It designs, develops, and sells veterinary drugs and non-medicinal products. The Company offers pain management, anti-infective, cardiology-nephrology, care and hygiene, behavior, internal medicine and reproduction-related products for dogs, cats, cattle, and pigs. 
Type
Public
Status
Active
Founded
1933
HQ
Lure, FR | view all locations
Website
http://www.vetoquinol.com/eng
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Dominique Derveaux

    Dominique Derveaux, COO, Chief Operating Officer

  • Matthieu Frechin
  • Philippe Gruet

    Philippe Gruet, Chief Scientific Officer (CSO)

  • Stijn van Dessel

    Stijn van Dessel, Group Director, Europe & Export

LocationsView all

27 locations detected

  • Lure, Bourgogne-Franche-Comté HQ

    France

    34 Rue du Chêne Sainte-Anne

  • Fort Worth, TX

    United States

    4250 N. Sylvania Ave.

  • Hamilton, QLD

    Australia

    L2/485 Kingsford Smith Dr

  • Wien, Wien

    Austria

    Gußhausstraße 14/5

  • Niel, Vlaams Gewest

    Belgium

    Galileilaan 11/401

  • Aparecida de Goiânia, GO

    Brazil

    Rua 11, Qd. 07, Lts. 47/55, Polo Empresarial Goiás

and 21 others

Vetoquinol Financials

Summary Financials

Revenue (FY, 2025)
€525.7M
Gross profit (FY, 2025)
€400.0M
Net income (FY, 2025)
€57.3M
Cash (FY, 2025)
€221.1M
EBIT (FY, 2025)
€78.2M
Enterprise value
$743.2M

Footer menu